Stay updated on Nivolumab with SBRT vs Alone in Metastatic HNSCC Clinical Trial
Sign up to get notified when there's something new on the Nivolumab with SBRT vs Alone in Metastatic HNSCC Clinical Trial page.
Latest updates to the Nivolumab with SBRT vs Alone in Metastatic HNSCC Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedPublication notes were updated to state that publications are automatically filled in from PubMed and may not all be about the study. The page revision label was updated to v3.3.2; to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%
- Check28 days agoChange DetectedRemoved the government funding operating status notice from the page; the study details, locations, and eligibility criteria remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%
- Check49 days agoChange DetectedNo additions or deletions were detected on the page; the content remains focused on the study details for NCT02684253.SummaryDifference0.4%
- Check70 days agoChange DetectedSignificant update: adds a government-status notice and a v3.2.0 version tag, removing the old v3.1.0 tag.SummaryDifference3%
- Check78 days agoChange DetectedUpdated version to v3.1.0 and removed the specific resource for head and neck squamous cell carcinoma; overall, this is a version update with a targeted resource removal.SummaryDifference0.5%
- Check92 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2, and the Back to Top link was removed; no core content, pricing, stock, or time-slot information was altered.SummaryDifference0.2%
Stay in the know with updates to Nivolumab with SBRT vs Alone in Metastatic HNSCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab with SBRT vs Alone in Metastatic HNSCC Clinical Trial page.